Opioid peptides are known to play a role in the function and growth of
the mammalian heart. Although some information about gene expression
of opioids in the heart is available, there is no data on the cellular
location of opioid gene expression during development or in the adult
. Using in situ hybridization and rat heart ranging from embryonic day
14 (E14) to adulthood, we have evaluated the distribution of gene exp
ression for proenkephalin, proopiomelanocortin, and prodynorphin. With
respect to preproenkephalin mRNA (PPE mRNA), message in the ventricle
was abundant from E14 (the first time point examined) until shortly a
fter birth, with a marked reduction noted on postnatal days 5, 10, and
21. Adults displayed considerable message, though less than in prepar
ations of embryonic and neonatal heart. PPE mRNA was detected in epica
rdial, myocardial, and endocardial cells as well as the walls of blood
vessels, capillaries, and fibroblasts. Preproopiomelanocortin (POMC)
mRNA was only found in adults, and was localized to the myocardium. Me
ssage for preprodynorphin could not be observed in the ventricles of d
eveloping or adult rats. These results are the first to define the tem
poral and spatial ontogeny of opioid gene expression with regard to th
e emergence of cardiac architecture. The data suggest that gene expres
sion for proenkephalin is especially prevalent in embryonic and neonat
al rats and may be related to the modulatory activity of the opioid gr
owth factor, [Met(5)]-enkephalin, on cell proliferation and differenti
ation. The role of PPE and POMC mRNA in adult rat heart requires eluci
dation. (C) 1998 Wiley-Liss, Inc.